FindTrial
Sign In

A Study on Peri-Operative Analgesic Usage in Breast Cancer Surgery

A Study On Peri-Operative Analgesic Usage in a Teritiary Care hospital for Breast Cancer Surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2021/12/038378
Enrollment
166
Registered
2021-12-02
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: D059- Unspecified type of carcinoma in situ of breast

Interventions

None listed

Sponsors

NIL
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All patients above the age of 18 years and undergoing oncological breast cancer surgery.

Exclusion criteria

Exclusion criteria: All patients with metastatic breast cancer and patients with renal Failure.

Design outcomes

Primary

MeasureTime frame
Assess the commonly prescribed analgesics usage pattern across various surgical unit in peri operative management of carcinoma breast.Timepoint: single point.—

Secondary

MeasureTime frame
To have an institutional analgesic policy for peri operative pain management in patients of oncological breast surgery.Timepoint: Single point.—

Countries

India

Contacts

Public ContactDr Caren DSouza

NGSM Institute of Pharmaceutical Sciences.

bharathraj@nitte.edu.in9035948490

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026